|
Market Closed -
OTC Markets
10:57:58 2026-06-03 EDT
|
5-day change | 1st Jan Change | ||
| 0.1052 USD | -2.09% |
|
+7.78% | -87.07% |
| 08-14 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-13 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 2.26M 2.06M 1.9M 1.73M 3.24M 209M 3.4M 23.08M 9.17M 114M 8.48M 8.3M 359M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 24.11M 21.96M 20.24M 18.41M 34.54M 2.23B 36.3M 246M 97.9M 1.22B 90.48M 88.57M 3.83B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.46% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| CASIF | Real-time | |
| CASI | Delayed |
| 1 day | +9.94% | ||
| 1 week | +7.78% | ||
| Current month | -15.51% | ||
| 1 month | +9.83% | ||
| 3 months | -14.64% | ||
| 6 months | -8.38% | ||
| Current year | -87.07% |
| 1 week | 0.1 | 0.11 | |
| 1 month | 0.1 | 0.13 | |
| Current year | 0.05 | 1.2 | |
| 1 year | 0.05 | 1.24 | |
| 3 years | 0.05 | 8.48 | |
| 5 years | 0.05 | 10.3 | |
| 10 years | 0.05 | 88.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 2025-07-20 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 2025-05-15 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 2013-03-31 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 2023-03-20 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 2023-03-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/18/26 | Emerging Technology Partners LLC
| Other | Company | 1,097,341 | 7.0830% | |
| 3/18/26 | Panacea Venture
| Other | Company | 4,529,956 | 29.2393% | |
| 3/18/26 | Other | Chief Financial Officer | 75,000 | 0.4841% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.09% | +7.78% | -91.06% | -98.07% | 2.26M | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,200B | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 651B | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 506B | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 377B | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 330B | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 288B | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 272B | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 236B | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 206B | ||
| Average | +1.29% | -3.29% | +13.41% | +58.27% | 407B | |
| Weighted average by Cap. | +0.30% | -5.19% | +26.02% | +87.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 25.99M 23.95M 21.79M 40.87M 2.64B 42.95M 291M 116M 1.44B 107M 105M 4.53B | 20.71M 18.86M 17.38M 15.81M 29.66M 1.92B 31.18M 212M 84.08M 1.05B 77.71M 76.07M 3.29B |
| Net income | -39.26M -35.76M -32.95M -29.97M -56.22M -3.64B -59.09M -401M -159M -1.99B -147M -144M -6.23B | -48.06M -43.77M -40.33M -36.69M -68.83M -4.45B -72.34M -491M -195M -2.43B -180M -177M -7.63B |
| Net Debt | 6.05M 5.51M 5.08M 4.62M 8.66M 560M 9.11M 61.8M 24.56M 306M 22.7M 22.22M 960M | 21.85M 19.9M 18.34M 16.68M 31.3M 2.02B 32.89M 223M 88.72M 1.11B 82M 80.27M 3.47B |
Employees
214
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-20 | US$0.1099 | +9.94% | 22,174 |
| 26-11-19 | US$0.1000 | -.--% | 235 |
| 26-11-16 | US$0.1000 | -1.96% | 10,115 |
| 26-11-13 | US$0.1020 | +2.00% | 260 |
- Stock Market
- Stocks
- CASIF Stock
Select your edition
All financial news and data tailored to specific country editions
















